Monthly Archives: August 2023

First human cases of West Nile Virus in Oklahoma reported

OKLAHOMA (KXII) – Oklahoma has four reported human cases of the West Nile virus, and one is considered severe. The Oklahoma State Department of Health reported that infected pools of mosquitos had been found in central, south central, and southeast portions of the state. The virus is spread by the Culex mosquito, which feeds on […]

Kentucky Blood Center giving $20 gift cards to donors Wednesday

LEXINGTON, Ky. (LEX 18) — The Kentucky Blood Center (KBC) will reward all blood donors with $20 Amazon gift cards on Wednesday, August 16th, 2023, for “Donor Appreciation Day.” According to KBC, 1-4 people will need a blood transfusion in their lifetime. Due to the trend of donation numbers decreasing during the summer, KBC says […]

UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis | University of Central Florida News

A College of Medicine researcher is developing a new antibiotic related to penicillin to treat tuberculosis (TB) and related lung infections. Kyle Rohde, an infectious disease expert, recently received a $3.4 million, five-year grant from the National Institutes of Health to create new antibiotics that target mycobacterial infections caused by pathogens such as Mycobacterium tuberculosis and Mycobacterium abscessus. […]

Study among first to show drugs targeting the lung, rather than bacteria, may prevent staph infection in flu patients

<div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2023/mount-sinai-study-amon.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2023/mount-sinai-study-amon.jpg" data-sub-html="Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI163402″> Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI163402 Influenza infection (flu) is a major cause of death around the world, especially during years of flu pandemics. People who die of the flu often have a secondary lung infection with Staphylococcus aureus (staph) bacteria that […]

FDA Grants Priority Review to Ivosidenib for IDH1+ Relapsed/Refractory MDS

Susan Pandya, MD The FDA has granted priority review to the supplemental new drug application (sNDA) seeking the approval of ivosidenib (Tibsovo) for the treatment of patients with IDH1-mutated, relapsed/refractory myelodysplastic syndrome (MDS).1 The sNDA is supported by data from a phase 1 trial (NCT02074839), which showed that evaluable patients with MDS in the efficacy […]

Air pollution raises risk of heart disease-related disability, death

Share on PinterestA recent study shows a correlation between air pollution exposure and cardiovascular events. zxvisual/Getty Images Researchers investigated the effects of air pollution on cardiovascular health. They found that air pollution is linked to higher numbers of years of life lost, deaths, and years spent in disability. The study found a correlation between air […]